Report Overview

A spurring demand for animal-derived food products, increasing awareness about pet healthcare, and the government’s initiatives promoting animal health are expected to drive India Animal Vaccine Market during the forecast period between 2024 and 2030.

India Animal Vaccine Market – Industry Trends & Forecast Report, 2030

India Animal Vaccine Market size by value was estimated at USD 1.34 billion in 2023. During the forecast period between 2024 and 2030, India Animal Vaccine Market size is projected to grow at a CAGR of 7.62% reaching a value of USD 4.87 billion by 2030. A prominent driver of the market is India's rising status as a global hub for vaccines and pharmaceuticals. The country harnesses its increasing technical expertise and robust infrastructure, which significantly bolster the expanding animal vaccine market. The rising prevalence of zoonotic diseases, growing livestock population, and increasing demand for animal products fuel market expansion. The pet healthcare sector is also booming, driven by higher incomes and evolving lifestyles.

By volume, India Animal Vaccine Market size was estimated at 285.2 million doses in 2023. During the forecast period between 2024 and 2030, India Animal Vaccine Market size is projected to grow at a CAGR of 7.01% reaching the volume of 376.1 million doses by 2030. The Indian Government’s initiatives like the National Animal Disease Control Program support comprehensive vaccination campaigns. Innovations such as thermotolerant vaccines and strategic R&D investments further bolster growth. The sector's future benefits from enhanced regulatory frameworks and a focus on improving livestock productivity and disease prevention.

Animal Vaccine – Overview

An animal vaccine is a biological preparation that stimulates an animal's immune system to produce immunity against specific infectious diseases, preventing or mitigating illness. These vaccines can be composed of live attenuated organisms, inactivated pathogens, or subunits like proteins or DNA, and are used to protect various species, including livestock, poultry, and pets, from diseases such as rabies, foot-and-mouth disease, and avian influenza. By promoting immunity, animal vaccines play a crucial role in maintaining animal health, enhancing food safety, and controlling the spread of zoonotic diseases, which can be transmitted from animals to humans.

India Animal Vaccine Market

Growth Drivers

Government’s Initiatives Promoting Animal Health

India's role as a global vaccination and pharmaceutical hub, supported by a skilled workforce and robust infrastructure, enhances its animal vaccine market. With a livestock population of 535 million, the country leads globally in livestock, cattle, and buffalo production. Government initiatives like the 'National Animal Disease Control Programme' and the 'Livestock Health and Disease Control (LH&DC) Scheme' are pivotal in promoting animal health. These programs aim to eradicate diseases such as Foot and Mouth Disease (FMD) and Brucellosis through comprehensive vaccination and disease control efforts. By implementing these proactive measures, the government significantly contributes to the growth and resilience of the animal healthcare sector, ensuring better disease management and boosting market opportunities.

Increasing Awareness of Pet Healthcare

The growth of India Animal Vaccine Market is significantly bolstered by the growing awareness about pet healthcare. With India being home to the world’s largest livestock population, the demand for effective vaccines has intensified. Key pharmaceutical and biotech companies, such as Indian Immunologicals Limited (IIL), Biovet, and Hester Biosciences, are pivotal in this sector. They collaborate extensively with global partners to develop vaccines tailored for various animals, including pets, cattle, and poultry. These efforts are crucial in combating prevalent diseases and enhancing overall animal health across the country. Government initiatives, such as the National Animal Disease Control Programme, further stimulate market growth by promoting vaccination among livestock and companion animals. As awareness grows among pet owners about the importance of preventive healthcare, the demand for vaccines continues to rise, positioning India as a key player in the global animal healthcare market.

Challenges

High Cost of Vaccines and Storage

India Animal Vaccine Market faces formidable challenges due to the high costs associated with vaccine production and storage. These expenses significantly impact accessibility and affordability, particularly for small-scale producers and rural areas. Addressing these challenges requires innovative solutions in vaccine manufacturing technologies and efficient cold chain logistics. The government’s support and the private sector’s increasing investments are crucial to mitigate these costs and ensure widespread availability of vaccines across diverse geographical regions, thereby enhancing animal health outcomes nationwide.

Impact of Escalating Geopolitical Tensions on India Animal Vaccine Market

Geopolitical tensions can have a multifaceted impact on India Animal Vaccine Market. These tensions can disrupt supply chains, hinder international collaborations crucial for vaccine development, and escalate production costs due to geopolitical uncertainties. Moreover, they may limit access to critical raw materials and technologies essential for vaccine manufacturing, thereby impacting production timelines and availability. To mitigate these impacts, India's animal vaccine industry must diversify its supply chains, bolster domestic manufacturing capabilities, and strengthen collaborations with regional partners. Such measures are essential to ensure uninterrupted access to vaccines, safeguard animal health, and sustain the market's growth trajectory amidst geopolitical uncertainties.

India Animal Vaccine Market

Segmental Coverage

India Animal Vaccine Market – By Product

By product, India Animal Vaccine Market is divided into Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, and Recombinant Vaccines segments. The recombinant vaccines segment holds the highest share in the India Animal Vaccine Market by product. These vaccines, developed through advanced biotechnological methods, offer significant advantages over traditional vaccines by eliminating disease-causing genes and enhancing safety. They are pivotal in combating diseases like foot-and-mouth disease (FMD) and anthrax without the risk of causing the diseases they prevent. The Indian market reflects a robust development landscape, with notable contributions from companies and research institutions focused on advancing biotech solutions for livestock health. This strategic emphasis underscores the critical role of recombinant vaccines in shaping the future of animal healthcare in India.

India Animal Vaccine Market – By Animal

Based on animal, India Animal Vaccine Market is split into Livestock and Companion segments. The livestock segment holds a higher share in the India Animal Vaccine Market by animal. It is primarily due to the vast population of cattle, buffaloes, sheep, goats, and pigs. This dominance is driven by the high demand for vaccines to prevent common diseases like Foot-and-Mouth Disease (FMD) and Brucellosis, which significantly impact livestock productivity and farmer income. The government’s initiatives, such as the National Animal Disease Control Programme (NADCP), focus heavily on vaccinating livestock to enhance health and production. Consequently, vaccines for livestock constitute the largest share of the market, reflecting their critical role in the Indian agricultural economy. Also, the livestock segment includes poultry, aqua, ruminants, and swine.

India Animal Vaccine Market – By Route of Administration

Based on route of administration, India Animal Vaccine Market is divided into Subcutaneous, Intramuscular, and Intranasal segments. The subcutaneous segment holds the highest share in the India Animal Vaccine Market by route of administration. In animals, subcutaneous injection sites are typically located behind the shoulder blades and neck. The ease and efficiency of administering drugs subcutaneously—where they are absorbed slowly—are key factors driving market growth. The subcutaneous route is not only quicker but also less painful for animals, making it a preferred method. Additionally, training veterinary professionals to administer subcutaneous injections is straightforward. Alongside subcutaneous injections, intramuscular routes are also widely used. These advantages collectively support the expansion of the animal vaccine market.

India Animal Vaccine Market – By Region

The in-depth research report on India Animal Vaccine Market covers the regional markets in North India, South India, East India, and West India regions. The West India region holds the highest share in India Animal Vaccine Market and is expected to maintain its dominance during the forecast period. It is due to its robust livestock population, advanced veterinary infrastructure, economic strength, and proactive government support. States like Maharashtra, Gujarat, and Rajasthan boast large populations of cattle, buffaloes, goats, and poultry, driving substantial demand for vaccines. Gujarat and Maharashtra are particularly notable as major dairy hubs, with Gujarat hosting Amul, the largest dairy cooperative in India, necessitating extensive vaccination programs to ensure animal health and productivity. The region’s high-quality veterinary services, bolstered by institutions like the ICAR-National Dairy Research Institute, support comprehensive vaccination efforts. Economically strong states provide better funding and infrastructure for livestock farming, with a significant presence of pharmaceutical and biotechnological companies ensuring a steady local supply of vaccines. Proactive state government programs and effective implementation of national schemes like the National Animal Disease Control Programme (NADCP) further enhance vaccination coverage. The suitable agro-climatic zones and high agricultural output complement livestock farming, increasing the demand for healthy, disease-free animals and driving the vaccine market in West India.

Competitive Landscape

Major players operating in India Animal Vaccine Market include Indian Immunologicals Limited, Hester Biosciences Limited, Brilliant Bio Pharma Pvt. Ltd., Biovet Private Limited, Venky's, Zoetis India, Merck Animal Health, Boehringer Ingelheim, and Ceva Santé Animale. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

• In December 2023 - Indian Immunologicals Limited (IIL), under the National Dairy Development Board, announced its plans to invest INR 700 crore in a new vaccine manufacturing plant in Hyderabad's Genome Valley. The state-of-the-art facility will feature a BSL3 (biosafety level) unit for drug substance production and a Fill-Finish capability for final vaccine products, focusing on Foot and Mouth Disease (FMD) and Haemorrhagic Septicaemia (HS). It has an annual capacity of 300 million doses.

• In June 2023 - The Nandi portal was inaugurated to facilitate the issuance of No Objection Certificates (NOCs) for veterinary drugs and vaccines. Developed by the Department of Animal Husbandry and Dairying (DAHD) in partnership with the Central Drugs Standard Control Organization (CDSCO), the Nandi portal integrates with the CDSCO's SUGAM portal to streamline the regulatory approval process. This initiative enhances transparency and efficiency in managing veterinary products.

Scope of the Report

By Product

• Attenuated Live Vaccines

• Inactivated Vaccines

• Subunit Vaccines

• DNA Vaccines

• Recombinant Vaccines

By Animal

• Livestock

• Companion

By Route of Administration

• Subcutaneous

• Intramuscular

• Intranasal

By Region

• North India

• South India

• East India

• West India